P Ljungman Selected Research

Transplantation (Transplant Recipients)

01/2008	Recent improvement in outcome of unrelated donor transplantation for aplastic anemia.
09/2005	Cell-mediated immune responses to influenza vaccination in healthy volunteers and allogeneic stem cell transplant recipients.
04/2005	Vaccination of stem cell transplant recipients: recommendations of the Infectious Diseases Working Party of the EBMT.
05/2004	Mycobacterial infection: a difficult and late diagnosis in stem cell transplant recipients.
03/2003	Cidofovir for adenovirus infections after allogeneic hematopoietic stem cell transplantation: a survey by the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.
10/2002	Human herpesvirus 6 infection and cytomegalovirus-specific lymphoproliferative responses in allogeneic stem cell transplant recipients.
12/2001	Practices of infectious disease prevention and management during hematopoietic stem cell transplantation: a survey from the European group for blood and marrow transplantation.
09/2001	Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.
04/2001	Progress in allogenic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983--93 and 1994--8 at European Group for Blood and Marrow Transplantation centres.
03/2001	Alpha-interferon maintenance treatment is associated with improved survival after high-dose treatment and autologous stem cell transplantation in patients with multiple myeloma: a retrospective registry study from the European Group for Blood and Marrow Transplantation (EBMT).
01/2001	Cidofovir for cytomegalovirus infection and disease in allogeneic stem cell transplant recipients. The Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.
01/2001	Prophylaxis against herpesvirus infections in transplant recipients.
09/2000	Haematopoietic stem cell transplantation for patients with myelo-dysplastic syndromes and secondary acute myeloid leukaemias: a report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
01/2000	Outcome of 69 allogeneic stem cell transplantations for Fanconi anemia using HLA-matched unrelated donors: a study on behalf of the European Group for Blood and Marrow Transplantation.
01/2000	Current results of bone marrow transplantation in patients with acquired severe aplastic anemia. Report of the European Group for Blood and Marrow transplantation. On behalf of the Working Party on Severe Aplastic Anemia of the European Group for Blood and Marrow Transplantation.
01/2000	Treatment of acquired severe aplastic anemia: bone marrow transplantation compared with immunosuppressive therapy--The European Group for Blood and Marrow Transplantation experience.

Articles by Research Topic

Disease

6	Communicable Diseases (Infectious Diseases) 04/2005 - 01/2001
5	Infection 08/2008 - 01/2001
5	Graft vs Host Disease (Graft-Versus-Host Disease) 11/2004 - 02/2000
3	Aplastic Anemia (Anemia, Hypoplastic) 01/2008 - 01/2000
3	Multiple Myeloma 03/2005 - 03/2001
2	Cystitis 04/2008 - 11/2004
2	Immune System Diseases (Immune Disorders) 03/2006 - 04/2002
2	Human Influenza (Influenza) 09/2005 - 02/2000
2	Cytomegalovirus Infections (Inclusion Disease) 01/2001 - 04/2000
1	Measles 10/2004
1	Adenoviridae Infections (Adenovirus Infections) 03/2003
1	Retinitis 06/2002
1	Neoplasms (Cancer) 06/2001
1	Herpesviridae Infections (Herpesvirus Infection) 01/2001
1	Herpes Zoster 01/2001
1	Breast Neoplasms (Breast Cancer) 10/2000
1	Syndrome 09/2000
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 02/2000
1	Residual Neoplasm 02/2000
1	Fanconi Anemia (Fanconi's Anemia) 01/2000

Drug/Important Bio-Agent (IBA)

2	cidofovir (Vistide)FDA Link 03/2003 - 01/2001
2	Acyclovir (Aciclovir)FDA LinkGeneric 06/2001 - 01/2001
1	valacyclovir (valaciclovir)FDA LinkGeneric 06/2001
1	Interferon-alpha (Interferon Alfa)FDA Link 03/2001
1	famciclovir (Famvir)FDA LinkGeneric 01/2001
1	Epirubicin (Ellence)FDA LinkGeneric 10/2000
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2000
1	Fluorouracil (Carac)FDA LinkGeneric 10/2000
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 02/2000

Therapy/Procedure

16	Transplantation (Transplant Recipients) 01/2008 - 01/2000
9	Stem Cell Transplantation 10/2004 - 01/2000
7	Transplants (Transplant) 04/2008 - 02/2000
5	Hematopoietic Stem Cell Transplantation 08/2008 - 12/2001
3	Bone Marrow Transplantation (Transplantation, Bone Marrow) 06/2002 - 01/2000
2	Autologous Transplantation (Autograft) 03/2006 - 04/2002
1	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 04/2001
1	Drug Therapy (Chemotherapy) 10/2000